bluuebunny/crossref_metadata_2025 huggingface dataset:
Supplementary Material from An F876L Mutation in Androgen Receptor Confers Genetic and Phenotypic Resistance to MDV3100 (Enzalutamide)
Authors: Korpal Manav , Korn Joshua M. , Gao Xueliang , Rakiec Daniel P. , Ruddy David A. , Doshi Shivang , Yuan Jing , Kovats Steve G. , Kim Sunkyu , Cooke Vesselina G. , Monahan John E. , Stegmeier Frank , Roberts Thomas M. , Sellers William R. , Zhou Wenlai , Zhu Ping
Published: April 2023

Supplementary Material - PDF file 198K, Supplementary figure legends, tables S1 and S2, and methods
Supplementary Figure 3 from NSD3–NUT Fusion Oncoprotein in NUT Midline Carcinoma: Implications for a Novel Oncogenic Mechanism
Authors: French Christopher A. , Rahman Shaila , Walsh Erica M. , Kühnle Simone , Grayson Adlai R. , Lemieux Madeleine E. , Grunfeld Noam , Rubin Brian P. , Antonescu Cristina R. , Zhang Songlin , Venkatramani Rajkumar , Dal Cin Paola , Howley Peter M.
Published: April 2023

PDF file - 213KB, Supplementary Fig. S3. Wild type NSD3 is required for the blockade of differentiation in BRD4-NUT-expressing NMC cells, 8645 and PER-403.
Figure S2 from Autophagy-Dependent Production of Secreted Factors Facilitates Oncogenic RAS-Driven Invasion
Authors: Lock Rebecca , Kenific Candia M. , Leidal Andrew M. , Salas Eduardo , Debnath Jayanta
Published: April 2023

PDF file 3189K, Effects of ATG depletion on mesenchymal differentiation and junctional integrity in HRASV12 MCF10A cells
Supplementary Data Figure 2 from Molecular Profiling of the Residual Disease of Triple-Negative Breast Cancers after Neoadjuvant Chemotherapy Identifies Actionable Therapeutic Targets
Authors: Balko Justin M. , Giltnane Jennifer M. , Wang Kai , Schwarz Luis J. , Young Christian D. , Cook Rebecca S. , Owens Phillip , Sanders Melinda E. , Kuba Maria G. , Sánchez Violeta , Kurupi Richard , Moore Preston D. , Pinto Joseph A. , Doimi Franco D. , Gómez Henry , Horiuchi Dai , Goga Andrei , Lehmann Brian D. , Bauer Joshua A. , Pietenpol Jennifer A. , Ross Jeffrey S. , Palmer Gary A. , Yelensky Roman , Cronin Maureen , Miller Vincent A. , Stephens Phillip J. , Arteaga Carlos L.
Published: April 2023

PDF file 26K, Association of node status with RFS and OS, stratified by menopausal status
Supplemental Table S3 from Development of siRNA Payloads to Target KRAS-Mutant Cancer
Authors: Yuan Tina L. , Fellmann Christof , Lee Chih-Shia , Ritchie Cayde D. , Thapar Vishal , Lee Liam C. , Hsu Dennis J. , Grace Danielle , Carver Joseph O. , Zuber Johannes , Luo Ji , McCormick Frank , Lowe Scott W.
Published: April 2023

Analysis of shRNA and endogenous miRNA representation.
Supplemental Table S2 from Development of siRNA Payloads to Target KRAS-Mutant Cancer
Authors: Yuan Tina L. , Fellmann Christof , Lee Chih-Shia , Ritchie Cayde D. , Thapar Vishal , Lee Liam C. , Hsu Dennis J. , Grace Danielle , Carver Joseph O. , Zuber Johannes , Luo Ji , McCormick Frank , Lowe Scott W.
Published: April 2023

Sequences of Sensor identified potent sh- and siRNAs targeting human and mouse Ras effector genes.
Supplemental References from Development of siRNA Payloads to Target KRAS-Mutant Cancer
Authors: Yuan Tina L. , Fellmann Christof , Lee Chih-Shia , Ritchie Cayde D. , Thapar Vishal , Lee Liam C. , Hsu Dennis J. , Grace Danielle , Carver Joseph O. , Zuber Johannes , Luo Ji , McCormick Frank , Lowe Scott W.
Published: April 2023

Supplemental References from Development of siRNA Payloads to Target KRAS-Mutant Cancer
Supplementary Tables 2 - 5, Figures 2 - 3 from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Authors: Stegeman Shane , Amankwah Ernest , Klein Kerenaftali , O'Mara Tracy A. , Kim Donghwa , Lin Hui-Yi , Permuth-Wey Jennifer , Sellers Thomas A. , Srinivasan Srilakshmi , Eeles Rosalind , Easton Doug , Kote-Jarai Zsofia , Amin Al Olama Ali , Benlloch Sara , Muir Kenneth , Giles Graham G. , Wiklund Fredrik , Gronberg Henrik , Haiman Christopher A. , Schleutker Johanna , Nordestgaard Børge G. , Travis Ruth C. , Neal David , Pharoah Paul , Khaw Kay-Tee , Stanford Janet L. , Blot William J. , Thibodeau Stephen , Maier Christiane , Kibel Adam S. , Cybulski Cezary , Cannon-Albright Lisa , Brenner Hermann , Kaneva Radka , Teixeira Manuel R. , Spurdle Amanda B. , Clements Judith A. , Park Jong Y. , Batra Jyotsna
Published: April 2023

Supplementary Table 2. Indolent versus aggressive disease analysis. Supplementary Table 3. Geometric mean PSA levels by genotype in cases and controls. Supplementary Table 4. Association of miRSNPs with prostate cancer risk in different age categories. Supplementary Table 5. Association of miRSNPs with expression of genes located in cis using TCGA SNP array and RNASeq data. Supplementary Figure 2. miRNA target reporter vector assays. Supplementary Figure 3. miR-3162-5p is expressed in prostate and prostate cancer-derived cell lines as well as in prostate cancer patient tissue samples.
Supplementary Table 1 from A Large-Scale Analysis of Genetic Variants within Putative miRNA Binding Sites in Prostate Cancer
Authors: Stegeman Shane , Amankwah Ernest , Klein Kerenaftali , O'Mara Tracy A. , Kim Donghwa , Lin Hui-Yi , Permuth-Wey Jennifer , Sellers Thomas A. , Srinivasan Srilakshmi , Eeles Rosalind , Easton Doug , Kote-Jarai Zsofia , Amin Al Olama Ali , Benlloch Sara , Muir Kenneth , Giles Graham G. , Wiklund Fredrik , Gronberg Henrik , Haiman Christopher A. , Schleutker Johanna , Nordestgaard Børge G. , Travis Ruth C. , Neal David , Pharoah Paul , Khaw Kay-Tee , Stanford Janet L. , Blot William J. , Thibodeau Stephen , Maier Christiane , Kibel Adam S. , Cybulski Cezary , Cannon-Albright Lisa , Brenner Hermann , Kaneva Radka , Teixeira Manuel R. , Spurdle Amanda B. , Clements Judith A. , Park Jong Y. , Batra Jyotsna
Published: April 2023

Supplementary Table 1. Prostate cancer risk estimates for 2169 putative miRSNPs.
Supplementary Figure Legends from Selective BCL-2 Inhibition by ABT-199 Causes On-Target Cell Death in Acute Myeloid Leukemia
Authors: Pan Rongqing , Hogdal Leah J. , Benito Juliana M. , Bucci Donna , Han Lina , Borthakur Gautam , Cortes Jorge , DeAngelo Daniel J. , Debose LaKeisha , Mu Hong , Döhner Hartmut , Gaidzik Verena I. , Galinsky Ilene , Golfman Leonard S. , Haferlach Torsten , Harutyunyan Karine G. , Hu Jianhua , Leverson Joel D. , Marcucci Guido , Müschen Markus , Newman Rachel , Park Eugene , Ruvolo Peter P. , Ruvolo Vivian , Ryan Jeremy , Schindela Sonja , Zweidler-McKay Patrick , Stone Richard M. , Kantarjian Hagop , Andreeff Michael , Konopleva Marina , Letai Anthony G.
Published: April 2023

Supplementary Figure Legends PDF file 92K, This file includes the supplemental figure legends
Supplementary Figures 1-10 from Human and Mouse VEGFA-Amplified Hepatocellular Carcinomas Are Highly Sensitive to Sorafenib Treatment
Authors: Horwitz Elad , Stein Ilan , Andreozzi Mariacarla , Nemeth Julia , Shoham Avivit , Pappo Orit , Schweitzer Nora , Tornillo Luigi , Kanarek Naama , Quagliata Luca , Zreik Farid , Porat Rinnat M. , Finkelstein Rutie , Reuter Hendrik , Koschny Ronald , Ganten Tom , Mogler Carolin , Shibolet Oren , Hess Jochen , Breuhahn Kai , Grunewald Myriam , Schirmacher Peter , Vogel Arndt , Terracciano Luigi , Angel Peter , Ben-Neriah Yinon , Pikarsky Eli
Published: April 2023

PDF file 1687K, The supplementary data contains immunostains, mRNA and DNA qPCR, ELISA analyses and descriptive cartoons including a model highlighting the manuscript
Supplementary Table 1 from Rare Mutations in RINT1 Predispose Carriers to Breast and Lynch Syndrome–Spectrum Cancers
Authors: Park Daniel J. , Tao Kayoko , Le Calvez-Kelm Florence , Nguyen-Dumont Tu , Robinot Nivonirina , Hammet Fleur , Odefrey Fabrice , Tsimiklis Helen , Teo Zhi L. , Thingholm Louise B. , Young Erin L. , Voegele Catherine , Lonie Andrew , Pope Bernard J. , Roane Terrell C. , Bell Russell , Hu Hao , Huff Chad D. , Ellis Jonathan , Li Jun , Makunin Igor V. , John Esther M. , Andrulis Irene L. , Terry Mary B. , Daly Mary , Buys Saundra S. , Snyder Carrie , Lynch Henry T. , Devilee Peter , Giles Graham G. , Hopper John L. , Feng Bing-Jian , Lesueur Fabienne , Tavtigian Sean V. , Southey Melissa C. , Goldgar David E.
Published: April 2023

PDF file 69K, Distribution of cases and controls included in the analysis, by study center and ethnic group
Supplementary Methods, Figures S1 - S10, Tables S1 - S2 from HOXB7 Is an ERα Cofactor in the Activation of HER2 and Multiple ER Target Genes Leading to Endocrine Resistance
Authors: Jin Kideok , Park Sunju , Teo Wei Wen , Korangath Preethi , Cho Sean Soonweng , Yoshida Takahiro , Győrffy Balázs , Goswami Chirayu Pankaj , Nakshatri Harikrishna , Cruz Leigh-Ann , Zhou Weiqiang , Ji Hongkai , Su Ying , Ekram Muhammad , Wu Zhengsheng , Zhu Tao , Polyak Kornelia , Sukumar Saraswati
Published: April 2023

Supplementary Figure S1 (related to Figure 1). HOXB7 microarray and ChIP-PED analysis. Supplementary Figure S2 (related to Figure 1). HOXB7 enhances expression of ER target genes. Supplementary Figure S3 (related to Figure 2). Validation of HOXB7 binding events to ER target genes. Supplementary Figure S4 (related to Figure 2). HOXB7 is required for ER target gene expression. Supplementary Figure S5 (related to Figure 3). Correlation between HOXB7 and HER2 expression. Supplementary Figure S6 (related to Figure 3). HOXB7 regulates HER2 expression. Supplementary Figure S7 (related to Figure 4). miRNA-196a regulates HOXB7 expression. Supplementary Figure S8 (related to Figure 5). MYC and miRNA-196a regulates HOXB7 expression. Supplementary Figure S9 (related to Figure 5). In vivo analysis of effects of inhibiting MYC and HER2 to overcome TAM-resistance in BT474 cells. Supplementary Figure S10 (related to Figure 6). MYC-HOXB7-HER2 predicts clinical outcome of breast cancer in women treated with endocrine therapy. Supplementary Table S1 (related to Figure 1), Family wise error rate (FWER) for MR-GSE of genes differentially expressed between MCF-7-HOXB7 and MCF-7-Vector cells. Supplementary Table S2 (related to Figure 1). ER target genes ranked in order of the average correlation with HOXB7 or ER.
Supplementary Figures S1 - S8 from IL35-Producing B Cells Promote the Development of Pancreatic Neoplasia
Authors: Pylayeva-Gupta Yuliya , Das Shipra , Handler Jesse S. , Hajdu Cristina H. , Coffre Maryaline , Koralov Sergei B. , Bar-Sagi Dafna
Published: April 2023

Supplementary Figure S1. Treatment with anti-CXCL13 antibody reduces B cell accumulation and growth of pancreatic neoplasia. Supplementary Figure S2. B cells promote growth of KrasG12D-PDEC in vivo. Supplementary Figure S3. Engraftment of GFP- KRasG12D-PDEC or GFP-KPC cells in microMT mice is accompanied by a switch in the polarization of the macrophage population. Supplementary Figure S4. Systemic perturbation of B lymphocyte maturation and differentiation in mice with pancreatic neoplasia. Supplementary Figure S5. Adoptive transfer of CD1dhighCD5+ and CD1dlowCD5- B cell subsets into microMT mice. Supplementary Figure S6. Expression of IL-10 in B cells infiltrating pancreatic cancer. Supplementary Figure S7. Expression of p35, IL12b and IL27 in B cells infiltrating pancreatic neoplasia. Supplementary Figure S8. Adoptive transfer of wild-type and IL12a-/- B cells into microMT mice.
Supplementary Figure 3 from Chronic Myelogenous Leukemia– Initiating Cells Require Polycomb Group Protein EZH2
Authors: Xie Huafeng , Peng Cong , Huang Jialiang , Li Bin E. , Kim Woojin , Smith Elenoe C. , Fujiwara Yuko , Qi Jun , Cheloni Giulia , Das Partha P. , Nguyen Minh , Li Shaoguang , Bradner James E. , Orkin Stuart H.
Published: April 2023

Sensitivity of CML cells to EZH2 inhibition.
Supplementary Figures S1 - S8 from Integrin-α10 Dependency Identifies RAC and RICTOR as Therapeutic Targets in High-Grade Myxofibrosarcoma
Authors: Okada Tomoyo , Lee Ann Y. , Qin Li-Xuan , Agaram Narasimhan , Mimae Takahiro , Shen Yawei , O'Connor Rachael , López-Lago Miguel A. , Craig Amanda , Miller Martin L. , Agius Phaedra , Molinelli Evan , Socci Nicholas D. , Crago Aimee M. , Shima Fumi , Sander Chris , Singer Samuel
Published: April 2023

Supplementary Figure S1, showing clustering of myxofibrosarcomas compared to normal tissue and showing the validation of the association of 5 genes with survival. Supplementary Figure S2, showing the effects of ITGA10 knockdown and overexpression. Supplementary Figure S3, showing the cell biology of integrin-alpha10 in myxofibrosarcoma cells. Supplementary Figure S4, showing the associations of TRIO and RICTOR amplification and overexpression with clinical outcomes. Supplementary Figure S5, showing that TRIO and RAC1 knockdown induce apoptosis in myxofibrosarcoma cells, but not in ASCs. Supplementary Figure S6, showing that RAPTOR knockdown does not induce apoptosis in myxofibrosarcoma cells. Supplementary Figure S7, showing the effects of RAC/PAK and mTOR inhibitors in myxofibrosarcoma cells and normal cells. Supplementary Figure S8, showing that mice treated with INK128 and/or EHop-016 maintain their weight.
Supplementary Figure S1 from Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S BTK Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma
Authors: Chiron David , Di Liberto Maurizio , Martin Peter , Huang Xiangao , Sharman Jeff , Blecua Pedro , Mathew Susan , Vijay Priyanka , Eng Ken , Ali Siraj , Johnson Amy , Chang Betty , Ely Scott , Elemento Olivier , Mason Christopher E. , Leonard John P. , Chen-Kiang Selina
Published: April 2023

Figure S1. MCL cell lines are differentially sensitive to killing and cell cycle control by ibrutinib.
Table S1-4 from Accelerating Discovery of Functional Mutant Alleles in Cancer
Authors: Chang Matthew T. , Bhattarai Tripti Shrestha , Schram Alison M. , Bielski Craig M. , Donoghue Mark T.A. , Jonsson Philip , Chakravarty Debyani , Phillips Sarah , Kandoth Cyriac , Penson Alexander , Gorelick Alexander , Shamu Tambudzai , Patel Swati , Harris Christopher , Gao JianJiong , Sumer Selcuk Onur , Kundra Ritika , Razavi Pedram , Li Bob T. , Reales Dalicia N. , Socci Nicholas D. , Jayakumaran Gowtham , Zehir Ahmet , Benayed Ryma , Arcila Maria E. , Chandarlapaty Sarat , Ladanyi Marc , Schultz Nikolaus , Baselga José , Berger Michael F. , Rosen Neal , Solit David B. , Hyman David M. , Taylor Barry S.
Published: April 2023

Supplementary Tables 1-4
Supplementary Methods, Figure Legends from In Vivo Genetic Screens of Patient-Derived Tumors Revealed Unexpected Frailty of the Transformed Phenotype
Authors: Bossi Daniela , Cicalese Angelo , Dellino Gaetano I. , Luzi Lucilla , Riva Laura , D'Alesio Carolina , Diaferia Giuseppe R. , Carugo Alessandro , Cavallaro Elena , Piccioni Rossana , Barberis Massimo , Mazzarol Giovanni , Testori Alessandro , Punzi Simona , Pallavicini Isabella , Tosti Giulio , Giacó Luciano , Melloni Giorgio , Heffernan Timothy P. , Natoli Gioacchino , Draetta Giulio F. , Minucci Saverio , Pelicci PierGiuseppe , Lanfrancone Luisa
Published: April 2023

Supplementary Methods, Figure Legends
Supplementary Data from Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia
Authors: Blombery Piers , Anderson Mary Ann , Gong Jia-nan , Thijssen Rachel , Birkinshaw Richard W. , Thompson Ella R. , Teh Charis E. , Nguyen Tamia , Xu Zhen , Flensburg Christoffer , Lew Thomas E. , Majewski Ian J. , Gray Daniel H.D. , Westerman David A. , Tam Constantine S. , Seymour John F. , Czabotar Peter E. , Huang David C.S. , Roberts Andrew W.
Published: April 2023

Supplementary Material
Figure S3 from MYC Instructs and Maintains Pancreatic Adenocarcinoma Phenotype
Authors: Sodir Nicole M. , Kortlever Roderik M. , Barthet Valentin J.A. , Campos Tania , Pellegrinet Luca , Kupczak Steven , Anastasiou Panayiotis , Swigart Lamorna Brown , Soucek Laura , Arends Mark J. , Littlewood Trevor D. , Evan Gerard I.
Published: April 2023

Histopathological progression of pancreatic tumors in KMp48 mice
protocol_2018.789990.pdf from Pan-Cancer Efficacy of Vemurafenib in BRAFV600-Mutant Non-Melanoma Cancers
Authors: Subbiah Vivek , Puzanov Igor , Blay Jean-Yves , Chau Ian , Lockhart A. Craig , Raje Noopur S. , Wolf Juergen , Baselga José , Meric-Bernstam Funda , Roszik Jason , Diamond Eli L. , Riely Gregory J. , Sherman Eric J. , Riehl Todd , Pitcher Bethany , Hyman David M.
Published: April 2023

Protocol appendix
Supplementary Table 4 from Combined Proteomic and Genetic Interaction Mapping Reveals New RAS Effector Pathways and Susceptibilities
Authors: Kelly Marcus R. , Kostyrko Kaja , Han Kyuho , Mooney Nancie A. , Jeng Edwin E. , Spees Kaitlyn , Dinh Phuong T. , Abbott Keene L. , Gwinn Dana M. , Sweet-Cordero E. Alejandro , Bassik Michael C. , Jackson Peter K.
Published: April 2023

Results from the single-target sgRNA screen in A549-Cas9 cells. The columns are as follows. Symbol : HUGO gene symbol ; EnsemblID : EnsEMBL identifier ; GeneID : Entrez Gene ID ; GeneInfo : Name of protein encoded by the gene ; Localization : GO cellular localization terms ; Process : GO cellular process terms ; Function : GO molecular function terms ; #Element: Number of identified sgRNAs in sequencing ; Phenotype (pZ) : median log2-fold enrichment of sgRNAS targeting this gene over the course of the experiment ; Tscore : GIT score ; MWU p-Val : p-value of gene depletion or enrichment by Mann-Whitney U test relative to Safe-sgRNAS ; MWU Adjusted Pval : FDR as determined by the Benjamini-Hochberg method.
Supplementary Data from PD-1 and LAG-3 Dominate Checkpoint Receptor–Mediated T-cell Inhibition in Renal Cell Carcinoma
Authors: Zelba Henning , Bedke Jens , Hennenlotter Jörg , Mostböck Sven , Zettl Markus , Zichner Thomas , Chandran Anoop , Stenzl Arnulf , Rammensee Hans-Georg , Gouttefangeas Cécile
Published: April 2023

Supplementary Tables/Figures: 7
Supplementary Figures and Table from Exercise Training Improves Tumor Control by Increasing CD8+ T-cell Infiltration via CXCR3 Signaling and Sensitizes Breast Cancer to Immune Checkpoint Blockade
Authors: Gomes-Santos Igor L. , Amoozgar Zohreh , Kumar Ashwin S. , Ho William W. , Roh Kangsan , Talele Nilesh P. , Curtis Hannah , Kawaguchi Kosuke , Jain Rakesh K. , Fukumura Dai
Published: April 2023

Supplemental Figures 1-11 and Supplementary table.
Figure S3 from CD86+ Antigen-Presenting B Cells Are Increased in Cancer, Localize in Tertiary Lymphoid Structures, and Induce Specific T-cell Responses
Authors: Wennhold Kerstin , Thelen Martin , Lehmann Jonas , Schran Simon , Preugszat Ella , Garcia-Marquez Maria , Lechner Axel , Shimabukuro-Vornhagen Alexander , Ercanoglu Meryem S. , Klein Florian , Thangarajah Fabinshy , Eidt Sebastian , Löser Heike , Bruns Christiane , Quaas Alexander , von Bergwelt-Baildon Michael , Schlößer Hans A.
Published: April 2023

Supplementary Figure 3: TLS accumulate primarily in the invasive margin.
Supplementary Table S4 from Chemotherapy Induces Tumor-Associated Macrophages that Aid Adaptive Immune Responses in Ovarian Cancer
Authors: Heath Owen , Berlato Chiara , Maniati Eleni , Lakhani Anissa , Pegrum Colin , Kotantaki Panoraia , Elorbany Samar , Böhm Steffen , Barry Simon T. , Annibaldi Alessandro , Barton Desmond P. , Balkwill Frances R.
Published: April 2023

List of DE genes in AZD vs Ctrl
Figure S1 Legend from High-Throughput Prediction of MHC Class I and II Neoantigens with MHCnuggets
Authors: Shao Xiaoshan M. , Bhattacharya Rohit , Huang Justin , Sivakumar I.K. Ashok , Tokheim Collin , Zheng Lily , Hirsch Dylan , Kaminow Benjamin , Omdahl Ashton , Bonsack Maria , Riemer Angelika B. , Velculescu Victor E. , Anagnostou Valsamo , Pagel Kymberleigh A. , Karchin Rachel
Published: April 2023

Supplemental Legend for Figure S1
Supplementary Data from Combining an Alarmin HMGN1 Peptide with PD-L1 Blockade Results in Robust Antitumor Effects with a Concomitant Increase of Stem-Like/Progenitor Exhausted CD8+ T Cells
Authors: Chen Chang-Yu , Ueha Satoshi , Ishiwata Yoshiro , Shichino Shigeyuki , Yokochi Shoji , Yang De , Oppenheim Joost J. , Ogiwara Haru , Deshimaru Shungo , Kanno Yuzuka , Aoki Hiroyasu , Ogawa Tatsuro , Shibayama Shiro , Matsushima Kouji
Published: April 2023

Supplementary Figures 1-5 and Supplementary table 1
Supplementary Figures 1-8 from Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
Authors: Drakes Dylan J. , Rafiq Sarwish , Purdon Terence J. , Lopez Andrea V. , Chandran Smita S. , Klebanoff Christopher A. , Brentjens Renier J.
Published: April 2023

Supplementary Figures 1-8
Supplementary Figure Legends from Optimization of T-cell Receptor–Modified T Cells for Cancer Therapy
Authors: Drakes Dylan J. , Rafiq Sarwish , Purdon Terence J. , Lopez Andrea V. , Chandran Smita S. , Klebanoff Christopher A. , Brentjens Renier J.
Published: April 2023

Supplementary Data Figure Legends
Figure S7 from Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer
Authors: Nair Nitya , Chen Shih-Yu , Lemmens Ed , Chang Serena , Le Dung T. , Jaffee Elizabeth M. , Murphy Aimee , Whiting Chan , Müller Thomas , Brockstedt Dirk G.
Published: April 2023

Cellular biomarkers are balanced across treatment arms in the validation patient cohort
Figure S4 from Single-Cell Immune Competency Signatures Associate with Survival in Phase II GVAX and CRS-207 Randomized Studies in Patients with Metastatic Pancreatic Cancer
Authors: Nair Nitya , Chen Shih-Yu , Lemmens Ed , Chang Serena , Le Dung T. , Jaffee Elizabeth M. , Murphy Aimee , Whiting Chan , Müller Thomas , Brockstedt Dirk G.
Published: April 2023

Training set patient sub-cohort is balanced in terms of candidate biomarker abundance at baseline
Supplementary Figures and Tables from Tumor Mutation Burden and Structural Chromosomal Aberrations Are Not Associated with T-cell Density or Patient Survival in Acral, Mucosal, and Cutaneous Melanomas
Authors: Edwards Jarem , Ferguson Peter M. , Lo Serigne N. , Pires da Silva Inês , Colebatch Andrew J. , Lee Hansol , Saw Robyn P.M. , Thompson John F. , Menzies Alexander M. , Long Georgina V. , Newell Felicity , Pearson John V. , Waddell Nicola , Hayward Nicholas K. , Johansson Peter A. , Mann Graham J. , Scolyer Richard A. , Palendira Umaimainthan , Wilmott James S.
Published: April 2023

Supplementary Figures 1-8 and Supplementary Tables 1-4
Supplementary Table 1 from Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Authors: Pavlick Anna , Blazquez Ana B. , Meseck Marcia , Lattanzi Michael , Ott Patrick A. , Marron Thomas U. , Holman Rose Marie , Mandeli John , Salazar Andres M. , McClain Christopher B. , Gimenez Gustavo , Balan Sreekumar , Gnjatic Sacha , Sabado Rachel Lubong , Bhardwaj Nina
Published: April 2023

Overlapping peptides covering the entire NY-ESO-1 protein
Figure S4 from γδ T Cells Support Antigen-Specific αβ T cell–Mediated Antitumor Responses during BCG Treatment for Bladder Cancer
Authors: Ji Niannian , Mukherjee Neelam , Shu Zhen-Ju , Reyes Ryan M. , Meeks Joshua J. , McConkey David J. , Gelfond Jonathan A. , Curiel Tyler J. , Svatek Robert S.
Published: April 2023

Figure.S4 shows that BCG treatment decreases PD-1 expression on mouse bladder tumor antigen-specific CD8+ T cell infiltrates.
Supplementary Figure 8 from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplementary Figure 8
Supplementary Figure 6 from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplementary Figure 6
Supplementary Figure 4 from Site-Dependent Immune Escape Due to Impaired Dendritic Cell Cross-Priming
Authors: Diamond Mark S. , Lin Jeffrey H. , Vonderheide Robert H.
Published: April 2023

Supplementary Figure 4
Supplementary Figure from Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression
Authors: Nirschl Christopher J. , Brodkin Heather R. , Hicklin Daniel J. , Ismail Nesreen , Morris Kristin , Seidel-Dugan Cynthia , Steiner Philipp , Steuert Zoe , Sullivan Jenna M. , Tyagi Ethika , Winston William M. , Salmeron Andres
Published: April 2023

Supplementary Figure from Discovery of a Conditionally Activated IL-2 that Promotes Antitumor Immunity and Induces Tumor Regression
Supplementary Figure from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
Authors: Alanio Cécile , Binder Zev A. , Chang Renee B. , Nasrallah MacLean P. , Delman Devora , Li Joey H. , Tang Oliver Y. , Zhang Logan Y. , Zhang Jiasi Vicky , Wherry E. John , O'Rourke Donald M. , Beatty Gregory L.
Published: April 2023

Supplementary Figure from Immunologic Features in De Novo and Recurrent Glioblastoma Are Associated with Survival Outcomes
Figures S1-S11 from APOBEC Mutagenesis Inhibits Breast Cancer Growth through Induction of T cell–Mediated Antitumor Immune Responses
Authors: DiMarco Ashley V. , Qin Xiaodi , McKinney Brock J. , Garcia Nina Marie G. , Van Alsten Sarah C. , Mendes Elizabeth A. , Force Jeremy , Hanks Brent A. , Troester Melissa A. , Owzar Kouros , Xie Jichun , Alvarez James V.
Published: April 2023

Supplementary Figures S1 - S11
Supplementary video 4 from Imaging α-GalCer–Activated iNKT Cells in a Hepatic Metastatic Environment
Authors: Babes Liane , Shim Raymond , Kubes Paul
Published: April 2023

Supplementary Video 4
Supplementary Table from Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma
Authors: DeRogatis Julia M. , Viramontes Karla M. , Neubert Emily N. , Henriquez Monique L. , Guerrero-Juarez Christian F. , Tinoco Roberto
Published: April 2023

Supplementary Table from Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma
Supplementary Figure from Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma
Authors: DeRogatis Julia M. , Viramontes Karla M. , Neubert Emily N. , Henriquez Monique L. , Guerrero-Juarez Christian F. , Tinoco Roberto
Published: April 2023

Supplementary Figure from Targeting the PSGL-1 Immune Checkpoint Promotes Immunity to PD-1–Resistant Melanoma
Supplementary Figures and Video Legends from Imaging α-GalCer–Activated iNKT Cells in a Hepatic Metastatic Environment
Authors: Babes Liane , Shim Raymond , Kubes Paul
Published: April 2023

Supplementary Figures 1-8 Plus Supplementary Video Legends
Supplementary Figure from Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects
Authors: Mary Romain , Chalmin Fanny , Accogli Théo , Bruchard Mélanie , Hibos Christophe , Melin Joséphine , Truntzer Caroline , Limagne Emeric , Derangère Valentin , Thibaudin Marion , Humblin Etienne , Boidot Romain , Chevrier Sandy , Arnould Laurent , Richard Corentin , Klopfenstein Quentin , Bernard Antoine , Urade Yoshihiro , Harker James A. , Apetoh Lionel , Ghiringhelli François , Végran Frédérique
Published: April 2023

Supplementary Figure from Hematopoietic Prostaglandin D2 Synthase Controls Tfh/Th2 Communication and Limits Tfh Antitumor Effects
Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Authors: Wen Ti , Barham Whitney , Li Ying , Zhang Henan , Gicobi Joanina K. , Hirdler Jacob B. , Liu Xin , Ham Hyoungjun , Peterson Martinez Kodi E. , Lucien Fabrice , Lavoie Roxane R. , Li Hu , Correia Cristina , Monie Dileep D. , An Zesheng , Harrington Susan M. , Wu Xiaosheng , Guo Ruifeng , Dronca Roxana S. , Mansfield Aaron S. , Yan Yiyi , Markovic Svetomir N. , Park Sean S. , Sun Jie , Qin Hong , Liu Minetta C. , Vasmatzis George , Billadeau Daniel D. , Dong Haidong
Published: April 2023

Supplementary Figure from NKG7 Is a T-cell–Intrinsic Therapeutic Target for Improving Antitumor Cytotoxicity and Cancer Immunotherapy
Supplementary Figure from Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand–Expressing Solid Tumors
Authors: Bajgain Pradip , Torres Chavez Alejandro G. , Balasubramanian Kishore , Fleckenstein Lindsey , Lulla Premal , Heslop Helen E. , Vera Juan , Leen Ann M.
Published: April 2023

Supplementary Figure from Secreted Fas Decoys Enhance the Antitumor Activity of Engineered and Bystander T Cells in Fas Ligand–Expressing Solid Tumors
Supplementary Table from ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Authors: Yang Mei , Miao Ya-Ru , Xie Gui-Yan , Luo Mei , Hu Hui , Kwok Hang Fai , Feng Jian , Guo An-Yuan
Published: April 2023

Supplementary Table from ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Supplementary Figure from ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Authors: Yang Mei , Miao Ya-Ru , Xie Gui-Yan , Luo Mei , Hu Hui , Kwok Hang Fai , Feng Jian , Guo An-Yuan
Published: April 2023

Supplementary Figure from ICBatlas: A Comprehensive Resource for Depicting Immune Checkpoint Blockade Therapy Characteristics from Transcriptome Profiles
Supplementary Table from Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer
Authors: Tsuji Shingo , Reil Katherine , Nelson Kinsey , Proclivo Veronica H. , McGuire Kathleen L. , Giacalone Matthew J.
Published: April 2023

Supplementary Table from Intravesical VAX014 Synergizes with PD-L1 Blockade to Enhance Local and Systemic Control of Bladder Cancer
Figure S1 from Extracellular Vesicle–Packaged circATP2B4 Mediates M2 Macrophage Polarization via miR-532-3p/SREBF1 Axis to Promote Epithelial Ovarian Cancer Metastasis
Authors: Wang Fang , Niu Yuequn , Chen Kelie , Yuan Xiaoyu , Qin Yuheng , Zheng Fang , Cui Zhenyan , Lu Weiguo , Wu Yihua , Xia Dajing
Published: April 2023

Supplementary Figure S1
Supplementary Data S3 from Rational Protein Design Yields a CD20 CAR with Superior Antitumor Efficacy Compared with CD19 CAR
Authors: Chen Ximin , Chen Laurence C. , Khericha Mobina , Meng Xiangzhi , Salvestrini Emma , Shafer Amanda , Iyer Neha , Alag Anya S. , Ding Yunfeng , Nicolaou Demetri M. , Chen Yvonne Y.
Published: April 2023

Differential chromatin accessible region and FPKM values from ATAC-seq on T cells harvested from tumor-bearing mice (Fig. 4E).
Data from Autoantibodies Drive Heart Damage Caused by Concomitant Radiation and PD-1 Blockade
Authors: Yan Bo , Hooper D. Craig , Yuan Zhiyong , Wang Changli , Chen Yulong , Lu Bo
Published: April 2023

Abstract
Concurrent PD-1 blockade and thoracic radiotherapy is being investigated in clinical trials for locally advanced, non–small cell lung cancer and small cell lung cancer, despite a potential overlapping risk of cardiotoxicity. Our prior studies demonstrate that cardiotoxicity from concurrent cardiac irradiation and anti–PD-1 administration in a mouse model is CD8+ T-cell dependent. The objective of this study was to determine whether humoral immunity contributed to the observed cardiac tissue damage, as measured by creatine kinase MB and cardiac troponin 1 release and decline in cardiac function. In the current study, we demonstrate the presence of cardiac autoantibodies, which were essential for the occurrence of cardiotoxicity from the combined therapy. Mice subjected to cardiac irradiation, while being treated with anti–PD-1, developed high levels of antibodies that reacted with cardiac tissues in vivo and cardiac antigens in vitro. Moreover, mice deficient in B cells were protected against cardiotoxicity, whereas the transfer of autoantibody-containing sera from mice that had received combined treatment reproduced the same pathologic phenotype in mice exposed to cardiac irradiation but was not observed in normal recipients. The cardiotoxic effect of the sera, which associated with CD8+ T-cell accumulation in cardiac tissue, was limited by IgG depletion. In conclusion, concurrent cardiac irradiation and PD-1 blockade leads to production of cardiac autoantibodies, likely due to antigen exposure within the irradiated cardiac tissues, which play a key role in the resulting cardiotoxicity.
Table S2 from An Autochthonous Mouse Model of Myd88- and BCL2-Driven Diffuse Large B-cell Lymphoma Reveals Actionable Molecular Vulnerabilities
Authors: Flümann Ruth , Rehkämper Tim , Nieper Pascal , Pfeiffer Pauline , Holzem Alessandra , Klein Sebastian , Bhatia Sanil , Kochanek Moritz , Kisis Ilmars , Pelzer Benedikt W. , Ahlert Heinz , Hauer Julia , da Palma Guerreiro Alexandra , Ryan Jeremy A. , Reimann Maurice , Riabinska Arina , Wiederstein Janica , Krüger Marcus , Deckert Martina , Altmüller Janine , Klatt Andreas R. , Frenzel Lukas P. , Pasqualucci Laura , Béguelin Wendy , Melnick Ari M. , Sander Sandrine , Montesinos-Rongen Manuel , Brunn Anna , Lohneis Philipp , Büttner Reinhard , Kashkar Hamid , Borkhardt Arndt , Letai Anthony , Persigehl Thorsten , Peifer Martin , Schmitt Clemens A. , Reinhardt Hans Christian , Knittel Gero
Published: April 2023

Pharmacological Screen IC50 values
Supplementary Figure 4 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Authors: Roels Juliette , Thénoz Morgan , Szarzyńska Bronisława , Landfors Mattias , De Coninck Stien , Demoen Lisa , Provez Lien , Kuchmiy Anna , Strubbe Steven , Reunes Lindy , Pieters Tim , Matthijssens Filip , Van Loocke Wouter , Erarslan-Uysal Büşra , Richter-Pechańska Paulina , Declerck Ken , Lammens Tim , De Moerloose Barbara , Deforce Dieter , Van Nieuwerburgh Filip , Cheung Laurence C. , Kotecha Rishi S. , Mansour Marc R. , Ghesquière Bart , Van Camp Guy , Berghe Wim Vanden , Kowalczyk Jerzy R. , Szczepański Tomasz , Davé Utpal P. , Kulozik Andreas E. , Goossens Steven , Curtis David J. , Taghon Tom , Dawidowska Małgorzata , Degerman Sofie , Van Vlierberghe Pieter
Published: April 2023

Supplementary Figure 4
Supplementary Figure 3 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Authors: Roels Juliette , Thénoz Morgan , Szarzyńska Bronisława , Landfors Mattias , De Coninck Stien , Demoen Lisa , Provez Lien , Kuchmiy Anna , Strubbe Steven , Reunes Lindy , Pieters Tim , Matthijssens Filip , Van Loocke Wouter , Erarslan-Uysal Büşra , Richter-Pechańska Paulina , Declerck Ken , Lammens Tim , De Moerloose Barbara , Deforce Dieter , Van Nieuwerburgh Filip , Cheung Laurence C. , Kotecha Rishi S. , Mansour Marc R. , Ghesquière Bart , Van Camp Guy , Berghe Wim Vanden , Kowalczyk Jerzy R. , Szczepański Tomasz , Davé Utpal P. , Kulozik Andreas E. , Goossens Steven , Curtis David J. , Taghon Tom , Dawidowska Małgorzata , Degerman Sofie , Van Vlierberghe Pieter
Published: April 2023

Supplementary Figure 3
Supplementary Figure 14 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Authors: Roels Juliette , Thénoz Morgan , Szarzyńska Bronisława , Landfors Mattias , De Coninck Stien , Demoen Lisa , Provez Lien , Kuchmiy Anna , Strubbe Steven , Reunes Lindy , Pieters Tim , Matthijssens Filip , Van Loocke Wouter , Erarslan-Uysal Büşra , Richter-Pechańska Paulina , Declerck Ken , Lammens Tim , De Moerloose Barbara , Deforce Dieter , Van Nieuwerburgh Filip , Cheung Laurence C. , Kotecha Rishi S. , Mansour Marc R. , Ghesquière Bart , Van Camp Guy , Berghe Wim Vanden , Kowalczyk Jerzy R. , Szczepański Tomasz , Davé Utpal P. , Kulozik Andreas E. , Goossens Steven , Curtis David J. , Taghon Tom , Dawidowska Małgorzata , Degerman Sofie , Van Vlierberghe Pieter
Published: April 2023

Supplementary Figure 14
Supplementary Figure 12 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Authors: Roels Juliette , Thénoz Morgan , Szarzyńska Bronisława , Landfors Mattias , De Coninck Stien , Demoen Lisa , Provez Lien , Kuchmiy Anna , Strubbe Steven , Reunes Lindy , Pieters Tim , Matthijssens Filip , Van Loocke Wouter , Erarslan-Uysal Büşra , Richter-Pechańska Paulina , Declerck Ken , Lammens Tim , De Moerloose Barbara , Deforce Dieter , Van Nieuwerburgh Filip , Cheung Laurence C. , Kotecha Rishi S. , Mansour Marc R. , Ghesquière Bart , Van Camp Guy , Berghe Wim Vanden , Kowalczyk Jerzy R. , Szczepański Tomasz , Davé Utpal P. , Kulozik Andreas E. , Goossens Steven , Curtis David J. , Taghon Tom , Dawidowska Małgorzata , Degerman Sofie , Van Vlierberghe Pieter
Published: April 2023

Supplementary Figure 12
Supplementary Figure 10 from Aging of Preleukemic Thymocytes Drives CpG Island Hypermethylation in T-cell Acute Lymphoblastic Leukemia
Authors: Roels Juliette , Thénoz Morgan , Szarzyńska Bronisława , Landfors Mattias , De Coninck Stien , Demoen Lisa , Provez Lien , Kuchmiy Anna , Strubbe Steven , Reunes Lindy , Pieters Tim , Matthijssens Filip , Van Loocke Wouter , Erarslan-Uysal Büşra , Richter-Pechańska Paulina , Declerck Ken , Lammens Tim , De Moerloose Barbara , Deforce Dieter , Van Nieuwerburgh Filip , Cheung Laurence C. , Kotecha Rishi S. , Mansour Marc R. , Ghesquière Bart , Van Camp Guy , Berghe Wim Vanden , Kowalczyk Jerzy R. , Szczepański Tomasz , Davé Utpal P. , Kulozik Andreas E. , Goossens Steven , Curtis David J. , Taghon Tom , Dawidowska Małgorzata , Degerman Sofie , Van Vlierberghe Pieter
Published: April 2023

Supplementary Figure 10
Supplementary Information from A Tumor Suppressor Enhancer of PTEN in T-cell Development and Leukemia
Authors: Tottone Luca , Lancho Olga , Loh Jui-Wan , Singh Amartya , Kimura Shunsuke , Roels Juliette , Kuchmiy Anna , Strubbe Steven , Lawlor Matthew A. , da Silva-Diz Victoria , Luo Shirley , Gachet Stéphanie , García-Prieto Carlos A. , Hagelaar Rico , Esteller Manel , Meijerink Jules P.P. , Soulier Jean , Taghon Tom , Van Vlierberghe Pieter , Mullighan Charles G. , Khiabanian Hossein , Rocha Pedro P. , Herranz Daniel
Published: April 2023

Supplementary Figures and Tables combined
SupplementaryTable1.xlsx from COVID-19 Infections and Clinical Outcomes in Patients with Multiple Myeloma in New York City: A Cohort Study from Five Academic Centers
Authors: Hultcrantz Malin , Richter Joshua , Rosenbaum Cara A. , Patel Dhwani , Smith Eric L. , Korde Neha , Lu Sydney X. , Mailankody Sham , Shah Urvi A. , Lesokhin Alexander M. , Hassoun Hani , Tan Carlyn , Maura Francesco , Derkach Andriy , Diamond Benjamin , Rossi Adriana , Pearse Roger N. , Madduri Deepu , Chari Ajai , Kaminetzky David , Braunstein Marc J. , Gordillo Christian , Reshef Ran , Taur Ying , Davies Faith E. , Jagannath Sundar , Niesvizky Ruben , Lentzsch Suzanne , Morgan Gareth J. , Landgren Ola
Published: April 2023

Supplementary Table 1
Supplementary Data from Monocytic Differentiation and AHR Signaling as Primary Nodes of BET Inhibitor Response in Acute Myeloid Leukemia
Authors: Romine Kyle A. , Nechiporuk Tamilla , Bottomly Daniel , Jeng Sophia , McWeeney Shannon K. , Kaempf Andy , Corces M. Ryan , Majeti Ravindra , Tyner Jeffrey W.
Published: April 2023

Supplementary Figures S1-S6, and Table S1-S3
Table S1-10 from Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
Authors: Brandsma Arianne M. , Bertrums Eline J.M. , van Roosmalen Markus J. , Hofman Damon A. , Oka Rurika , Verheul Mark , Manders Freek , Ubels Joske , Belderbos Mirjam E. , van Boxtel Ruben
Published: April 2023

Supplementary Table S1-10 providing details on study cohorts and sequencing results
Figure S1-S6 from Mutation Signatures of Pediatric Acute Myeloid Leukemia and Normal Blood Progenitors Associated with Differential Patient Outcomes
Authors: Brandsma Arianne M. , Bertrums Eline J.M. , van Roosmalen Markus J. , Hofman Damon A. , Oka Rurika , Verheul Mark , Manders Freek , Ubels Joske , Belderbos Mirjam E. , van Boxtel Ruben
Published: April 2023

Supplementary Figures S1-S6 with figure legends
Supplementary Table S6 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Authors: Feusier Julie E. , Arunachalam Sasi , Tashi Tsewang , Baker Monika J. , VanSant-Webb Chad , Ferdig Amber , Welm Bryan E. , Rodriguez-Flores Juan L. , Ours Christopher , Jorde Lynn B. , Prchal Josef T. , Mason Clinton C.
Published: April 2023

CHIP mutations at hotspots identified in the three non-cancer cohorts
Supplementary Table S4 from Large-scale Identification of Clonal Hematopoiesis and Mutations Recurrent in Blood Cancers
Authors: Feusier Julie E. , Arunachalam Sasi , Tashi Tsewang , Baker Monika J. , VanSant-Webb Chad , Ferdig Amber , Welm Bryan E. , Rodriguez-Flores Juan L. , Ours Christopher , Jorde Lynn B. , Prchal Josef T. , Mason Clinton C.
Published: April 2023

Allowable mutations for confident CHIP calling
Supplementary Table 8 from SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Authors: Yan Dongqing , Franzini Anca , Pomicter Anthony D. , Halverson Brayden J. , Antelope Orlando , Mason Clinton C. , Ahmann Jonathan M. , Senina Anna V. , Vellore Nadeem A. , Jones Courtney L. , Zabriskie Matthew S. , Than Hein , Xiao Michael J. , van Scoyk Alexandria , Patel Ami B. , Clair Phillip M. , Heaton William L. , Owen Shawn C. , Andersen Joshua L. , Egbert Christina M. , Reisz Julie A. , D'Alessandro Angelo , Cox James E. , Gantz Kevin C. , Redwine Hannah M. , Iyer Siddharth M. , Khorashad Jamshid S. , Rajabi Nima , Olsen Christian A. , O'Hare Thomas , Deininger Michael W.
Published: April 2023

Plasmids.
Supplementary Table 7 from SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Authors: Yan Dongqing , Franzini Anca , Pomicter Anthony D. , Halverson Brayden J. , Antelope Orlando , Mason Clinton C. , Ahmann Jonathan M. , Senina Anna V. , Vellore Nadeem A. , Jones Courtney L. , Zabriskie Matthew S. , Than Hein , Xiao Michael J. , van Scoyk Alexandria , Patel Ami B. , Clair Phillip M. , Heaton William L. , Owen Shawn C. , Andersen Joshua L. , Egbert Christina M. , Reisz Julie A. , D'Alessandro Angelo , Cox James E. , Gantz Kevin C. , Redwine Hannah M. , Iyer Siddharth M. , Khorashad Jamshid S. , Rajabi Nima , Olsen Christian A. , O'Hare Thomas , Deininger Michael W.
Published: April 2023

Antibodies.
Supplementary Table 2 from SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Authors: Yan Dongqing , Franzini Anca , Pomicter Anthony D. , Halverson Brayden J. , Antelope Orlando , Mason Clinton C. , Ahmann Jonathan M. , Senina Anna V. , Vellore Nadeem A. , Jones Courtney L. , Zabriskie Matthew S. , Than Hein , Xiao Michael J. , van Scoyk Alexandria , Patel Ami B. , Clair Phillip M. , Heaton William L. , Owen Shawn C. , Andersen Joshua L. , Egbert Christina M. , Reisz Julie A. , D'Alessandro Angelo , Cox James E. , Gantz Kevin C. , Redwine Hannah M. , Iyer Siddharth M. , Khorashad Jamshid S. , Rajabi Nima , Olsen Christian A. , O'Hare Thomas , Deininger Michael W.
Published: April 2023

Ranked list of 1,287 genes from shRNA library screen in primary AML cells. The 1,287 genes assessed with an shRNA library screen were sorted by the second highest percentile fold change present in 2 shRNA and across 2 samples, with the 34 genes showing a fold change in the top 2 percent in more than 2 samples listed first.
Supplementary Figures from SIRT5 Is a Druggable Metabolic Vulnerability in Acute Myeloid Leukemia
Authors: Yan Dongqing , Franzini Anca , Pomicter Anthony D. , Halverson Brayden J. , Antelope Orlando , Mason Clinton C. , Ahmann Jonathan M. , Senina Anna V. , Vellore Nadeem A. , Jones Courtney L. , Zabriskie Matthew S. , Than Hein , Xiao Michael J. , van Scoyk Alexandria , Patel Ami B. , Clair Phillip M. , Heaton William L. , Owen Shawn C. , Andersen Joshua L. , Egbert Christina M. , Reisz Julie A. , D'Alessandro Angelo , Cox James E. , Gantz Kevin C. , Redwine Hannah M. , Iyer Siddharth M. , Khorashad Jamshid S. , Rajabi Nima , Olsen Christian A. , O'Hare Thomas , Deininger Michael W.
Published: April 2023

All supplemental figures and legends.
Supplementary Table S1 from Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
Authors: Renneville Aline , Gasser Jessica A. , Grinshpun Daniel E. , Jean Beltran Pierre M. , Udeshi Namrata D. , Matyskiela Mary E. , Clayton Thomas , McConkey Marie , Viswanathan Kaushik , Tepper Alexander , Guirguis Andrew A. , Sellar Rob S. , Cotteret Sophie , Marzac Christophe , Saada Véronique , De Botton Stéphane , Kiladjian Jean-Jacques , Cayuela Jean-Michel , Rolfe Mark , Chamberlain Philip P. , Carr Steven A. , Ebert Benjamin L.
Published: April 2023

Supplementary Table 1. Proteomic data
Supplementary Data from Avadomide Induces Degradation of ZMYM2 Fusion Oncoproteins in Hematologic Malignancies
Authors: Renneville Aline , Gasser Jessica A. , Grinshpun Daniel E. , Jean Beltran Pierre M. , Udeshi Namrata D. , Matyskiela Mary E. , Clayton Thomas , McConkey Marie , Viswanathan Kaushik , Tepper Alexander , Guirguis Andrew A. , Sellar Rob S. , Cotteret Sophie , Marzac Christophe , Saada Véronique , De Botton Stéphane , Kiladjian Jean-Jacques , Cayuela Jean-Michel , Rolfe Mark , Chamberlain Philip P. , Carr Steven A. , Ebert Benjamin L.
Published: April 2023

Supplementary Methods, Figures, and Tables
Supplemental Table 2A&2B from Predictors of Humoral Response to SARS-CoV-2 Vaccination after Hematopoietic Cell Transplantation and CAR T-cell Therapy
Authors: Tamari Roni , Politikos Ioannis , Knorr David A. , Vardhana Santosha A. , Young Jennifer C. , Marcello LeeAnn T. , Doddi Sital , Devlin Sean M. , Ramanathan Lakshmi V. , Pessin Melissa S. , Dunn Erica , Palazzo Meighan , Bravo Christina D. , Papanicolaou Genovefa A. , Kamboj Mini , Perales Miguel Angel , Chung David J. , Shah Gunjan L.
Published: April 2023

2A- MVA for the whole cohort 2B-MVA for patients who underwent allo-HCT only
Table S6 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
Authors: Koya Junji , Saito Yuki , Kameda Takuro , Kogure Yasunori , Yuasa Mitsuhiro , Nagasaki Joji , McClure Marni B. , Shingaki Sumito , Tabata Mariko , Tahira Yuki , Akizuki Keiichi , Kamiunten Ayako , Sekine Masaaki , Shide Kotaro , Kubuki Yoko , Hidaka Tomonori , Kitanaka Akira , Nakano Nobuaki , Utsunomiya Atae , Togashi Yosuke , Ogawa Seishi , Shimoda Kazuya , Kataoka Keisuke
Published: April 2023

Differentially expressed mRNAs, significantly enriched pathways, and differentially expressed ADTs between clusters or subclusters
Table S4 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
Authors: Koya Junji , Saito Yuki , Kameda Takuro , Kogure Yasunori , Yuasa Mitsuhiro , Nagasaki Joji , McClure Marni B. , Shingaki Sumito , Tabata Mariko , Tahira Yuki , Akizuki Keiichi , Kamiunten Ayako , Sekine Masaaki , Shide Kotaro , Kubuki Yoko , Hidaka Tomonori , Kitanaka Akira , Nakano Nobuaki , Utsunomiya Atae , Togashi Yosuke , Ogawa Seishi , Shimoda Kazuya , Kataoka Keisuke
Published: April 2023

mRNA and ADT markers for each subcluster
Table S2 from Single-Cell Analysis of the Multicellular Ecosystem in Viral Carcinogenesis by HTLV-1
Authors: Koya Junji , Saito Yuki , Kameda Takuro , Kogure Yasunori , Yuasa Mitsuhiro , Nagasaki Joji , McClure Marni B. , Shingaki Sumito , Tabata Mariko , Tahira Yuki , Akizuki Keiichi , Kamiunten Ayako , Sekine Masaaki , Shide Kotaro , Kubuki Yoko , Hidaka Tomonori , Kitanaka Akira , Nakano Nobuaki , Utsunomiya Atae , Togashi Yosuke , Ogawa Seishi , Shimoda Kazuya , Kataoka Keisuke
Published: April 2023

ADTs used in this study
Supplementary Data from Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia
Authors: Kaushal Akhilesh , Nooka Ajay K. , Carr Allison R. , Pendleton Katherine E. , Barwick Benjamin G. , Manalo Julia , McCachren Samuel S. , Gupta Vikas A. , Joseph Nisha S. , Hofmeister Craig C. , Kaufman Jonathan L. , Heffner Leonard T. , Ansell Stephen M. , Boise Lawrence H. , Lonial Sagar , Dhodapkar Kavita M. , Dhodapkar Madhav V.
Published: April 2023

supplementary figs 1-25 and supplementary tables 1-3